259 related articles for article (PubMed ID: 35138624)
1. The Functional Properties, Physiological Roles, Channelopathy and Pharmacological Characteristics of the Slack (KCNT1) Channel.
Zhang Q; Liu Y; Xu J; Teng Y; Zhang Z
Adv Exp Med Biol; 2021; 1349():387-400. PubMed ID: 35138624
[TBL] [Abstract][Full Text] [Related]
2. Functional evaluation of epilepsy-associated KCNT1 variants in multiple cellular systems reveals a predominant gain of function impact on channel properties.
Hinckley CA; Zhu Z; Chu JH; Gubbels C; Danker T; Cherry JJ; Whelan CD; Engle SJ; Nguyen V
Epilepsia; 2023 Aug; 64(8):2126-2136. PubMed ID: 37177976
[TBL] [Abstract][Full Text] [Related]
3. Potassium channelopathies associated with epilepsy-related syndromes and directions for therapeutic intervention.
Gribkoff VK; Winquist RJ
Biochem Pharmacol; 2023 Feb; 208():115413. PubMed ID: 36646291
[TBL] [Abstract][Full Text] [Related]
4. The Phe932Ile mutation in KCNT1 channels associated with severe epilepsy, delayed myelination and leukoencephalopathy produces a loss-of-function channel phenotype.
Evely KM; Pryce KD; Bhattacharjee A
Neuroscience; 2017 May; 351():65-70. PubMed ID: 28366665
[TBL] [Abstract][Full Text] [Related]
5. Functional Effects of Epilepsy Associated
Rychkov GY; Shaukat Z; Lim CX; Hussain R; Roberts BJ; Bonardi CM; Rubboli G; Meaney BF; Whitney R; Møller RS; Ricos MG; Dibbens LM
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499459
[TBL] [Abstract][Full Text] [Related]
6. Disease-causing Slack potassium channel mutations produce opposite effects on excitability of excitatory and inhibitory neurons.
Wu J; Quraishi IH; Zhang Y; Bromwich M; Kaczmarek LK
Cell Rep; 2024 Mar; 43(3):113904. PubMed ID: 38457342
[TBL] [Abstract][Full Text] [Related]
7. New use for an old drug: quinidine in KCNT1-related epilepsy therapy.
Liu R; Sun L; Wang Y; Wang Q; Wu J
Neurol Sci; 2023 Apr; 44(4):1201-1206. PubMed ID: 36437393
[TBL] [Abstract][Full Text] [Related]
8. An Epilepsy-Associated KCNT1 Mutation Enhances Excitability of Human iPSC-Derived Neurons by Increasing Slack K
Quraishi IH; Stern S; Mangan KP; Zhang Y; Ali SR; Mercier MR; Marchetto MC; McLachlan MJ; Jones EM; Gage FH; Kaczmarek LK
J Neurosci; 2019 Sep; 39(37):7438-7449. PubMed ID: 31350261
[TBL] [Abstract][Full Text] [Related]
9. Two Patients With KCNT1-Related Epilepsy Responding to Phenobarbital and Potassium Bromide.
Datta AN; Michoulas A; Guella I; ; Demos M
J Child Neurol; 2019 Oct; 34(12):728-734. PubMed ID: 31208268
[No Abstract] [Full Text] [Related]
10. Targeting K
Cole BA; Clapcote SJ; Muench SP; Lippiat JD
Trends Pharmacol Sci; 2021 Aug; 42(8):700-713. PubMed ID: 34074526
[TBL] [Abstract][Full Text] [Related]
11. Impaired motor skill learning and altered seizure susceptibility in mice with loss or gain of function of the Kcnt1 gene encoding Slack (K
Quraishi IH; Mercier MR; McClure H; Couture RL; Schwartz ML; Lukowski R; Ruth P; Kaczmarek LK
Sci Rep; 2020 Feb; 10(1):3213. PubMed ID: 32081855
[TBL] [Abstract][Full Text] [Related]
12. KCNT1 mutations in seizure disorders: the phenotypic spectrum and functional effects.
Lim CX; Ricos MG; Dibbens LM; Heron SE
J Med Genet; 2016 Apr; 53(4):217-25. PubMed ID: 26740507
[TBL] [Abstract][Full Text] [Related]
13. Drosophila expressing mutant human KCNT1 transgenes make an effective tool for targeted drug screening in a whole animal model of KCNT1-epilepsy.
Hussain R; Lim CX; Shaukat Z; Islam A; Caseley EA; Lippiat JD; Rychkov GY; Ricos MG; Dibbens LM
Sci Rep; 2024 Feb; 14(1):3357. PubMed ID: 38336906
[TBL] [Abstract][Full Text] [Related]
14. K
Gertler TS; Cherian S; DeKeyser JM; Kearney JA; George AL
Neurobiol Dis; 2022 Jun; 168():105713. PubMed ID: 35346832
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel de novo p.Phe932Ile KCNT1 mutation in a patient with leukoencephalopathy and severe epilepsy.
Vanderver A; Simons C; Schmidt JL; Pearl PL; Bloom M; Lavenstein B; Miller D; Grimmond SM; Taft RJ
Pediatr Neurol; 2014 Jan; 50(1):112-4. PubMed ID: 24120652
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular characterization of
McTague A; Nair U; Malhotra S; Meyer E; Trump N; Gazina EV; Papandreou A; Ngoh A; Ackermann S; Ambegaonkar G; Appleton R; Desurkar A; Eltze C; Kneen R; Kumar AV; Lascelles K; Montgomery T; Ramesh V; Samanta R; Scott RH; Tan J; Whitehouse W; Poduri A; Scheffer IE; Chong WKK; Cross JH; Topf M; Petrou S; Kurian MA
Neurology; 2018 Jan; 90(1):e55-e66. PubMed ID: 29196579
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of a novel series of 1,2,4-oxadiazole inhibitors of SLACK potassium channels: Identification of in vitro tool VU0935685.
Qunies AM; Spitznagel BD; Du Y; David Weaver C; Emmitte KA
Bioorg Med Chem; 2023 Nov; 95():117487. PubMed ID: 37812884
[TBL] [Abstract][Full Text] [Related]
18. Phactr1 regulates Slack (KCNT1) channels via protein phosphatase 1 (PP1).
Ali SR; Malone TJ; Zhang Y; Prechova M; Kaczmarek LK
FASEB J; 2020 Jan; 34(1):1591-1601. PubMed ID: 31914597
[TBL] [Abstract][Full Text] [Related]
19. In silico model reveals the key role of GABA in KCNT1-epilepsy in infancy with migrating focal seizures.
Kuchenbuch M; Nabbout R; Yochum M; Sauleau P; Modolo J; Wendling F; Benquet P
Epilepsia; 2021 Mar; 62(3):683-697. PubMed ID: 33617692
[TBL] [Abstract][Full Text] [Related]
20. Emerging role of the KCNT1 Slack channel in intellectual disability.
Kim GE; Kaczmarek LK
Front Cell Neurosci; 2014; 8():209. PubMed ID: 25120433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
